ATE484587T1 - Ldcam genannte moleküle - Google Patents

Ldcam genannte moleküle

Info

Publication number
ATE484587T1
ATE484587T1 AT99942039T AT99942039T ATE484587T1 AT E484587 T1 ATE484587 T1 AT E484587T1 AT 99942039 T AT99942039 T AT 99942039T AT 99942039 T AT99942039 T AT 99942039T AT E484587 T1 ATE484587 T1 AT E484587T1
Authority
AT
Austria
Prior art keywords
ldcam
molecules called
polypeptides
purified
compositions
Prior art date
Application number
AT99942039T
Other languages
English (en)
Inventor
Peter Baum
William Fanslow
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE484587T1 publication Critical patent/ATE484587T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Vending Machines For Individual Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT99942039T 1998-08-07 1999-08-05 Ldcam genannte moleküle ATE484587T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9567298P 1998-08-07 1998-08-07
PCT/US1999/017905 WO2000008158A2 (en) 1998-08-07 1999-08-05 Molecules designated ldcam

Publications (1)

Publication Number Publication Date
ATE484587T1 true ATE484587T1 (de) 2010-10-15

Family

ID=22253083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99942039T ATE484587T1 (de) 1998-08-07 1999-08-05 Ldcam genannte moleküle

Country Status (11)

Country Link
US (5) US7402655B2 (de)
EP (1) EP1102848B1 (de)
JP (1) JP4426724B2 (de)
AT (1) ATE484587T1 (de)
AU (1) AU776825B2 (de)
CA (1) CA2337100C (de)
DE (1) DE69942861D1 (de)
ES (1) ES2353637T3 (de)
IL (3) IL140937A0 (de)
NZ (1) NZ510356A (de)
WO (1) WO2000008158A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008158A2 (en) * 1998-08-07 2000-02-17 Immunex Corporation Molecules designated ldcam
WO2000032633A1 (en) * 1998-12-02 2000-06-08 Icos Corporation Novel adhesion molecule and methods of use
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1067182A3 (de) * 1999-07-08 2001-11-21 Helix Research Institute Sekretorische- oder Membranproteine
EP1222205A4 (de) * 1999-10-18 2004-03-31 Texas Biotechnology Corp Polynukleotide die für menschliche und maus-adhäsionsproteine (bigr) kodieren.
WO2002014557A1 (en) * 2000-08-15 2002-02-21 The Johns Hopkins University School Of Medecine Diagnosis and treatment of tumor-suppressor associated disorders
MY140679A (en) * 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
US20050232896A1 (en) * 2001-10-04 2005-10-20 Herbert Schwarz Cd137 as a proliferation factor for hematopoietic stem cells
EP1536821A4 (de) * 2002-06-17 2009-09-09 Wyeth Corp Hemmung der t-zellaktivierung durch butyrophilin 4 oder b7-l1
ES2383328T3 (es) * 2003-07-25 2012-06-20 Amgen, Inc Métodos relacionados con LDCAM y CRTAM
EP2069793B9 (de) 2006-08-29 2017-08-16 Oxford BioTherapeutics Ltd Identifizierung von mit hepatozellulärem karzinom, glioblastom und lungenkrebs assoziiertem protein
US8737317B2 (en) * 2008-05-13 2014-05-27 Qualcomm Incorporated Autonomous carrier selection for femtocells
UA102891C2 (uk) 2009-03-05 2013-08-27 Медарекс, Інк. Повні людські антитіла, специфічні до cadm1
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9708375B2 (en) 2013-03-15 2017-07-18 Amgen Inc. Inhibitory polypeptides specific to WNT inhibitors
EP3041863A4 (de) 2013-09-05 2017-08-16 Amgen Inc. Fc-haltige moleküle mit vorhersagbaren, konsistenten und reproduzierbaren glycoformprofilen
CA2949237C (en) 2014-05-16 2022-08-23 Amgen Inc. Assay for detecting th1 and th2 cell populations
US11978336B2 (en) 2015-07-07 2024-05-07 Ilumi Solutions, Inc. Wireless control device and methods thereof
EP4131199B1 (de) 2015-07-07 2025-07-23 Ilumi Solutions, Inc. Verfahren zur drahtlosen kommunikation
CA3056011A1 (en) 2017-03-14 2018-09-20 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
CN111954719B (zh) 2018-03-26 2025-07-18 美国安进公司 细胞培养物中产生的抗体的总去岩藻糖基化糖型
BR112022005583A2 (pt) 2019-09-26 2022-09-20 Amgen Inc Métodos para a produção de composições de anticorpos
EP4162257A1 (de) 2020-06-04 2023-04-12 Amgen Inc. Beurteilung von reinigungsvorgängen eines biotherapeutischen herstellungsverfahrens
KR20230087539A (ko) 2020-10-15 2023-06-16 암젠 인크 항체 생산 방법에서의 상대적인 비결합 글리칸
TW202317614A (zh) 2021-06-07 2023-05-01 美商安進公司 使用岩藻糖苷酶控制糖基化蛋白的去岩藻糖基化水平
WO2023059607A1 (en) 2021-10-05 2023-04-13 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
WO2024220916A1 (en) 2023-04-20 2024-10-24 Amgen Inc. Methods of determining relative unpaired glycan content
WO2025038600A1 (en) 2023-08-14 2025-02-20 Amgen Inc. Methods for reducing yellow color
WO2025101820A1 (en) 2023-11-08 2025-05-15 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
US20020165143A1 (en) * 1997-12-03 2002-11-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL136216A0 (en) * 1997-12-03 2001-05-20 Genentech Inc Polypeptides and nucleic acids encoding the same
EP1077991A1 (de) 1998-05-07 2001-02-28 Genetics Institute, Inc. Sekretitierte proteine und diese kodierende polynukleotide
EP1108042B1 (de) * 1998-08-07 2008-11-26 Immunex Corporation B7l-1 moleküle
WO2000008158A2 (en) * 1998-08-07 2000-02-17 Immunex Corporation Molecules designated ldcam
CA2348824A1 (en) 1998-10-28 2000-05-25 Human Genome Sciences, Inc. 12 human secreted proteins
EP1135495A2 (de) 1998-12-01 2001-09-26 Genentech, Inc. Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure
JP2003503040A (ja) 1999-06-30 2003-01-28 シグマ−アルドリッチ・カンパニー 合成ペプチド免疫原およびそれに対する抗体
AU2001233041A1 (en) 2000-01-25 2001-08-07 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001296301A1 (en) 2000-09-26 2002-04-08 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Also Published As

Publication number Publication date
IL140937A (en) 2010-05-31
US20100215572A1 (en) 2010-08-26
US20090011499A1 (en) 2009-01-08
DE69942861D1 (de) 2010-11-25
IL193886A0 (en) 2009-05-04
US7659385B2 (en) 2010-02-09
EP1102848A2 (de) 2001-05-30
EP1102848B1 (de) 2010-10-13
IL193886A (en) 2010-12-30
US20090155845A1 (en) 2009-06-18
CA2337100C (en) 2011-09-20
US20040204568A1 (en) 2004-10-14
WO2000008158A3 (en) 2000-05-11
AU5550399A (en) 2000-02-28
WO2000008158A2 (en) 2000-02-17
ES2353637T3 (es) 2011-03-03
US20020168712A1 (en) 2002-11-14
US7402655B2 (en) 2008-07-22
AU776825B2 (en) 2004-09-23
JP4426724B2 (ja) 2010-03-03
IL140937A0 (en) 2002-02-10
CA2337100A1 (en) 2000-02-17
US7741115B2 (en) 2010-06-22
JP2002523021A (ja) 2002-07-30
NZ510356A (en) 2004-12-24

Similar Documents

Publication Publication Date Title
ATE484587T1 (de) Ldcam genannte moleküle
ATE415480T1 (de) B7l-1 moleküle
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DK1482040T3 (da) NL3-TIE-receptortyrosinkinaseligandhomologer
DK1129190T3 (da) Human TSLP DNA og polypeptider
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
PT917571E (pt) Gene relacionado com agouti
DE69535696D1 (de) Tripeptidyl-aminopeptidase
AU7303301A (en) Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
SE9801455D0 (sv) New receptor
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
SE9602822D0 (sv) New receptor
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
ATE408687T1 (de) Semaphorin polypeptide
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
SE9604439D0 (sv) New receptor
ATE283358T1 (de) Protease-ähnliches protein
HK1031229A (en) Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties